Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERα and p53

Veterinary Journal

Volumn 179, Issue 3, 2009, Pages 422-429

  Morris, Joanna S ^a   Nixon, Colin ^a   King, Oliver J A ^a   Morgan, Iain M ^a   Philbey, Adrian W ^a  

^a Faculty of Veterinary Medicine   (United Kingdom)

Author keywords

Canine; ER ; Immunohistochemistry; Ki67; Mammary tumours; p53; TopBP1

Indexed keywords

BRCA1 PROTEIN; ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; PROTEIN P53; TOPOISOMERASE IIBETA BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BREAST ADENOMA; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST TUMOR; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE MUTATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; BRCA1 PROTEIN; CARRIER PROTEINS; DOG DISEASES; DOGS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MAMMARY NEOPLASMS, ANIMAL; TUMOR SUPPRESSOR PROTEIN P53;

FELIDAE;

EID: 58949088965     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2007.10.025     Document Type: Article

References (39)

1. Barchi M., Mahadevaiah S., Di Giacomo M., Baudat F., de Rooij D.G., Burgoyne P.S., Jasin M., and Keeney S. Surveillance of different recombination defects in mouse spermatocytes yields distinct responses despite elimination at an identical developmental stage. Molecular Cell Biology 25 (2005) 7203-7215
2. Birgisdottir V., Stefansson O.A., Bodvarsdottir S.K., Hilmarsdottir H., Jonasson J.G., and Eyfjord J.E. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Research 8 (2006) R38
3. Boner W., Taylor E.R., Tsirimonaki E., Yamane K., Campo M.S., and Morgan I.M. A Functional interaction between the human papillomavirus 16 transcription/replication factor E2 and the DNA damage response protein TopBP1. Journal of Biological Chemistry 277 (2002) 22297-22303
4. Bostock D.E. Canine and feline mammary neoplasms. British Veterinary Journal 142 (1986) 506-515
5. Clancy J.L., Henderson M.J., Russell A.J., Anderson D.W., Bova R.J., Campbell I.G., Choong D.Y., Macdonald G.A., Mann G.J., Nolan T., Brady G., Olopade O.I., Woollatt E., Davies M.J., Segara D., Hacker N.F., Henshall S.M., Sutherland R.L., and Watts C.K. EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer. Oncogene 22 (2003) 5070-5081
6. Fabbro M., Schuechner S., Au W.W., and Henderson B.R. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention. Experimental Cell Research 298 (2004) 661-673
7. Fraser J.A., Reeves J.R., Stanton P.D., Black D.M., Going J.J., Cooke T.G., and Bartlett J.M. A role for BRCA1 in sporadic breast cancer. British Journal of Cancer 88 (2003) 1263-1270
8. Gamblin R.M., Sagartz J.E., and Couto C.G. Overexpression of p53 tumor suppressor protein in spontaneously arising neoplasms of dogs. American Journal of Veterinary Research 58 (1997) 857-863
9. Geraldes M., Gartner F., and Schmitt F. Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours. Veterinary Record 146 (2000) 403-406
10. Going J.J., Nixon C., Dornan E.S., Boner W., Donaldson M.M., and Morgan I.M. Aberrant expression of TopBP1 in breast cancer. Histopathology 50 (2007) 418-424
11. Hellmen, E., 2005. Complex mammary tumours in the female dog: a review. Journal of Dairy Research 72 Spec No., pp. 90-97.
12. Inoue M., and Shiramizu K. Immunohistochemical detection of p53 and c-myc proteins in canine mammary tumours. Journal of Comparative Pathology 120 (1999) 169-175
13. Karppinen S.M., Erkko H., Reini K., Pospiech H., Heikkinen K., Rapakko K., Syvaoja J.E., and Winqvist R. Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer. European Journal of Cancer 42 (2006) 2647-2652
14. Landberg G., Tan E.M., and Roos G. Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell cycle. Experimental Cell Research 187 (1990) 111-118
15. Lee C.H., Kim W.H., Lim J.H., Kang M.S., Kim D.Y., and Kweon O.K. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. Journal of Veterinary Science 5 (2004) 63-69
16. Lohr C.V., Teifke J.P., Failing K., and Weiss E. Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA. Veterinary Pathology 34 (1997) 212-221
17. Makiniemi M., Hillukkala T., Tuusa J., Reini K., Vaara M., Huang D., Pospiech H., Majuri I., Westerling T., Makela T.P., and Syvaoja J.E. BRCT domain-containing protein TopBP1 functions in DNA replication and damage response. Journal of Biological Chemistry 276 (2001) 30399-30406
18. Martín de Las Mulas J., Millan Y., and Dios R. A prospective analysis of immunohistochemically determined estrogen receptor α and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog. Veterinary Pathology 42 (2005) 200-212
19. Millanta F., Calandrella M., Bari G., Niccolini M., Vannozzi I., and Poli A. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Research in Veterinary Science 79 (2005) 225-232
20. Misdorp W. Tumors of the mammary gland. In: Meuten D.J. (Ed). Tumors in Domestic Animals (2002), Blackwell, Oxford 575-606
21. Misdorp W., Else R.W., Hellmen E., and Lipscomb T.P. Histological Classification of Mammary Tumors of the Dog and the Cat (1999), Armed Forces Institute of Pathology, Washington DC (second series, vol. VII)
22. Morris J.S., Nixon C., Bruck A., Nasir L., Morgan I.M., and Philbey A.W. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERα and p53. The Veterinary Journal 175 2 (2008) 218-226
23. Muto T., Wakui S., Takahashi H., Maekawa S., Masaoka T., Ushigome S., and Furusato M. p53 gene mutations occurring in spontaneous benign and malignant mammary tumors of the dog. Veterinary Pathology 37 (2000) 248-253
24. Nieto A., Pena L., Perez-Alenza M.D., Sanchez M.A., Flores J.M., and Castano M. Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Veterinary Pathology 37 (2000) 239-247
25. Nieto A., Perez-Alenza M.D., Del Castillo N., Tabanera E., Castano M., and Pena L. BRCA1 expression in canine mammary dysplasias and tumours: relationship with prognostic variables. Journal of Comparative Pathology 128 (2003) 260-268
26. Rio P.G., Maurizis J.C., Peffault de Latour M., Bignon Y.J., and Bernard-Gallon D.J. Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene. International Journal of Cancer 80 (1999) 823-826
27. Rodriguez J.A., Au W.W., and Henderson B.R. Cytoplasmic mislocalization of BRCA1 caused by cancer-associated mutations in the BRCT domain. Experimental Cell Research 293 (2004) 14-21
28. Rungsipipat A., Tateyama S., Yamaguchi R., Uchida K., Miyoshi N., and Hayashi T. Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors. Journal of Veterinary Medical Science 61 (1999) 27-32
29. Rutteman G.R., Misdorp W., Blankenstein M.A., and van den Brom W.E. Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: different receptor profile in non-malignant and malignant states. British Journal of Cancer 58 (1988) 594-599
30. Sarli G., Preziosi R., Benazzi C., Castellani G., and Marcato P.S. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors. Journal of Veterinary Diagnostic Investigation 14 (2002) 25-34
31. Scully R., Xie A., and Nagaraju G. Molecular functions of BRCA1 in the DNA damage response. Cancer Biology and Therapy 3 (2004) 521-527
32. Thompson M.E., Jensen R.A., Obermiller P.S., Page D.L., and Holt J.T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genetics 9 (1995) 444-450
33. Tibbetts R.S., Cortez D., Brumbaugh K.M., Scully R., Livingston D., Elledge S.J., and Abraham R.T. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes and Development 14 (2000) 2989-3002
34. Yamane K., Kawabata M., and Tsuruo T. A DNA-topoisomerase-II-binding protein with eight repeating regions similar to DNA-repair enzymes and to a cell-cycle regulator. European Journal of Biochemistry 250 (1997) 794-799
35. Yamane K., Wu X., and Chen J. A DNA damage-regulated BRCT-containing protein, TopBP1, is required for cell survival. Molecular Cell Biology 22 (2002) 555-566
36. Yamane K., Chen J., and Kinsella T.J. Both DNA topoisomerase II-binding protein 1 and BRCA1 regulate the G2-M cell cycle checkpoint. Cancer Research 63 (2003) 3049-3053
37. Yang W.Y., Liu C.H., Chang C.J., Lee C.C., Chang K.J., and Lin C.T. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours. Journal of Comparative Pathology 134 (2006) 70-79
38. Zacchetti A., van Garderen E., Teske E., Nederbragt H., Dierendonck J.H., and Rutteman G.R. Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry. Apmis 111 (2003) 430-438
39. Zhou B.B., and Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 408 (2000) 433-439